Scientific work

Prof. Dr. Ömer Fatih Ölmez

163 publications. The source of the information is stated next to each publication.

Back to profile

  1. 2008P The effect of the use of complex molecular profiling in advanced solid organ tumours on clinical decision: Turkey molecular profiling in advanced cancers trial (TUMPACT)

    Annals of Oncology, 2020

    DOI 10.1016/j.annonc.2020.08.1314 Open-access full textSource: OpenAlex

  2. GLASS: Global Lorlatinib for ALK(+) and ROS1(+) retrospective Study: real world data of 123 NSCLC patients

    Lung Cancer, 2020

    DOI 10.1016/j.lungcan.2020.07.022 PMID 32799090 30 citations (Europe PMC) Source: OpenAlex

  3. Atezolizumab in Patients with Metastatic Urothelial Carcinoma Who Have Progressed After First-line Chemotherapy: Results of Real-life Experiences

    European Urology Focus, 2020

    DOI 10.1016/j.euf.2020.09.010 PMID 33008789 8 citations (Europe PMC) Source: ORCID

  4. Papilledema: Could It Be an Important Clinical Sign of Leptomeningeal Metastasis?

    Medical Bulletin of Haseki, 2020

    DOI 10.4274/haseki.galenos.2020.6190 Open-access full textSource: ORCID

  5. Atezolizumab in patients with metastatic urothelial carcinoma who have progressed after first-line chemotherapy: Results of real-life experience.

    Journal of Clinical Oncology, 2020

    DOI 10.1200/jco.2020.38.6_suppl.451 3 citations (OpenAlex) Source: OpenAlex

  6. 781P Prognostic factors in patients with metastatic urothelial carcinoma who have been treated with atezolizumab

    Annals of Oncology, 2020

    DOI 10.1016/j.annonc.2020.08.853 Open-access full textSource: OpenAlex

  7. P1.14-01 Are Pretreatment Inflammation-Based Prognostic Scores Useful in Predicting the Outcomes of Patients with ALK-Positive NSCLC?

    Journal of Thoracic Oncology, 2019

    DOI 10.1016/j.jtho.2019.08.1152 Open-access full textSource: OpenAlex

  8. P2.01-64 Systemic Inflammatory Markers as a Predictors of Response to Crizotinib in Patients with ALK-Positive Non-Small-Cell Lung Cancer

    Journal of Thoracic Oncology, 2019

    DOI 10.1016/j.jtho.2019.08.1407 Open-access full textSource: OpenAlex

  9. Are Pretreatment Inflammation-Based Prognostic Scores Useful in Predicting the Outcomes of Patients with ALK-Positive NSCLC?

    Van Yüzüncü Yıl University Academic Data Management System, 2019

    Source: OpenAlex

  10. Prognostic Significance of Metastatic Lymph Node Ratio in Patients with pN3 Gastric Cancer Who Underwent Curative Gastrectomy

    Oncology Research and Treatment, 2019

    DOI 10.1159/000496746 PMID 30870846 18 citations (Europe PMC) Source: OpenAlex

  11. Platelet to lymphocyte ratio is associated with tumour localization and outcomes in patients with metastatic colorectal cancer

    Annals of Oncology, 2019

    DOI 10.1093/annonc/mdz421.042 Open-access full textSource: OpenAlex

  12. P1.14-15 Lorlatinib in ALK- or ROS1-Positive Non-Small Cell Lung Cancer Patients: Experience from an Early Access Program in Turkey

    Journal of Thoracic Oncology, 2019

    DOI 10.1016/j.jtho.2019.08.1166 3 citations (OpenAlex) Open-access full textSource: OpenAlex

  13. Is there any prognostic significance in pleural involvement and/or effusion (Ple-I/E) in patients with ALK-positive NSCLC?

    Annals of Oncology, 2019

    DOI 10.1093/annonc/mdz260.069 Open-access full textSource: OpenAlex

  14. metastatik meme kanseri tedavisindelapatinib kapesitabinkombinasyonunun retrospektif değerlendirilmesi

    Bursa Uludag University - AVESIS, 2019

    Source: OpenAlex

  15. Mide Kanserlerinde İmmünoterapiler: PD-1 ve PD-L1 İnhibitörleri

    Turkiye Klinikleri Medical Oncology - Special Topics, 2019

    Source: OpenAlex

  16. Anti-Ri-associated paraneoplastic neurological syndrome: Initial symptom of breast cancer with HER2 overexpression and treatment by dual HER2 blockade

    Journal of Oncology Pharmacy Practice, 2018

    DOI 10.1177/1078155218792672 PMID 30124121 6 citations (Europe PMC) Source: OpenAlex

  17. P1.01-45 Crizotinib Efficacy in ALK-Positive Advanced Stage Non-Small Cell Lung Cancer Patients: A Real-World Experience from Turkey

    Journal of Thoracic Oncology, 2018

    DOI 10.1016/j.jtho.2018.08.601 Open-access full textSource: OpenAlex

  18. Crizotinib Efficacy in ALK-positive Advanced Stage Non-Small Cell Lung Cancer Patients: A Real-World Experince from Turkey

    Van Yüzüncü Yıl University Academic Data Management System, 2018

    Source: OpenAlex

  19. Crizotinib Efficacy in ALK-positive Advanced Stage Non-Small Cell Lung Cancer Patients: A Real-World Experience from Turkey

    Bursa Uludag University - AVESIS, 2018

    Source: OpenAlex

  20. CRIZOTINIB EFFICACY IN ALK-POSITIVE ADVANCEDSTAGE NON-SMALL CELL LUNG CANCER PATIENTS: A REAL-WORLD EXPERIENCE FROM TURKEY

    Kocaeli Üniversitesi - AVESİS, 2018

    Source: OpenAlex

  21. Metastatik Meme Kanseri Tedavisinde Lapatinib Kapesitabin Kombinasyonun Etkinliğinin Retrospektif Değerlendirilmesi

    Uludağ Üniversitesi Tıp Fakültesi Dergisi, 2018

    DOI 10.32708/uutfd.485507 Open-access full textSource: OpenAlex

  22. Experience from Turkish centers participating in the Early Access Program (EAP): Preliminary real-world safety data of nivolumab (nivo) combined with ipilimumab (ipi) in pre-treated advanced melanoma patients

    Journal of Oncological Sciences, 2018

    DOI 10.1016/j.jons.2018.10.001 3 citations (OpenAlex) Open-access full textSource: OpenAlex

  23. The efficacy and safety of crizotinib in patients with ROS1 positive advanced stage NSCLC: The real-world experience from Turkey

    AYBU AVESIS, 2018

    Source: OpenAlex

  24. Kanserde Palyatif Tedaviler: Palyatif Kemoterapi Uygulamaları

    Van Yüzüncü Yıl University Academic Data Management System, 2017

    Source: OpenAlex

  25. P2.01-063 Outcomes of Patients with Oligometastatic Non-Small Cell Lung Cancer Who Were Treated with Radical Treatment

    Journal of Thoracic Oncology, 2017

    DOI 10.1016/j.jtho.2017.09.1165 Open-access full textSource: OpenAlex

  26. Immunohistochemical expression of human epidermal growth factor receptor (HER)-4 and prognosis in patients with metastatic breast cancer.

    PubMed, 2016

    PMID 27569073 Source: OpenAlex

  27. Are neutrophil/lymphocyte ratio and platelet/lymphocyte ratio associated with prognosis in patients with HER2-positive early breast cancer receiving adjuvant trastuzumab?

    Journal of B.U.ON. : official journal of the Balkan Union of Oncology, 2015

    PMID 26214622 36 citations (Europe PMC) Open-access full textSource: ORCID

  28. Patients with HER2-positive Early Breast Cancer Receiving Adjuvant Trastuzumab: Clinicopathological Features, Efficacy, and Factors Affecting Survival

    Asian Pacific Journal of Cancer Prevention, 2015

    DOI 10.7314/apjcp.2015.16.4.1643 PMID 25743846 2 citations (Europe PMC) Open-access full textSource: ORCID

  29. Prognostic impact of tumor lymphocytic infiltrates in patients with breast cancer undergoing neoadjuvant chemotherapy

    Journal of B.U.ON., 2015

    PMID 26416041 10 citations (OpenAlex) Open-access full textSource: ORCID

  30. Neoadjuvant chemotherapy-induced changes in immunohistochemical expression of estrogen receptor, progesterone receptor, HER2, and Ki-67 in patients with breast cancer.

    PubMed, 2015

    PMID 25778295 20 citations (OpenAlex) Source: OpenAlex

  31. Association and Prognostic Significance of the Functional −1562C/T Polymorphism in the Promoter Region of MMP-9 in Turkish Patients with Gastric Cancer

    Pathology & Oncology Research, 2015

    DOI 10.1007/s12253-015-9950-7 PMID 26156886 9 citations (OpenAlex) Source: OpenAlex

  32. Metastatik Böbrek Kanserinde Tedavi

    Turkiye Klinikleri Medical Oncology - Special Topics, 2015

    Source: OpenAlex

  33. Lack of prognostic significance of adiponectin immunohistochemical expression in patients with triple-negative breast cancer

    Współczesna Onkologia, 2014

    DOI 10.5114/wo.2014.40454 PMID 24876819 3 citations (Europe PMC) Open-access full textSource: OpenAlex

  34. Cisplatin Plus Etoposide in the Adjuvant Treatment of Patients with Non-Small Cell Lung Cancer

    The Annals of Clinical and Analytical Medicine, 2014

    DOI 10.4328/jcam.1469 Open-access full textSource: OpenAlex

  35. Efficacy of Sunitinib in Patients with Imatinib-Resistant Gastrointestinal Stromal Tumors

    The Annals of Clinical and Analytical Medicine, 2014

    DOI 10.4328/jcam.1375 Source: OpenAlex

  36. Malignant melanoma of the stomach in an elderly patient

    The Turkish Journal of Gastroenterology, 2014

    DOI 10.5152/tjg.2014.3845 PMID 25910348 2 citations (OpenAlex) Open-access full textSource: OpenAlex

  37. Prognostic significance of estrogen receptor, progesterone receptor, HER2/neu, Ki-67, and nm23 expression in patients with invasive breast cancer.

    PubMed, 2013

    PMID 23818346 4 citations (Europe PMC) Source: OpenAlex

  38. Prognostic Significance of Human Epidermal Receptor (HER)-3 Immunohistochemical Expression in Patients with Metastatic Breast Cancer

    Asian Pacific Journal of Cancer Prevention, 2013

    DOI 10.7314/apjcp.2013.14.7.4115 PMID 23991962 2 citations (Europe PMC) Open-access full textSource: OpenAlex

  39. Lokal İleri veya Metastatik Pankreas Kanserli Hastalarımızın Retrospektif Değerlendirilmesi

    DergiPark (Istanbul University), 2013

    Open-access full textSource: OpenAlex

  40. A multi-institutional evaluation of carboplatin plus docetaxel regimen in elderly patients with advanced gastric cancer.

    PubMed, 2013

    PMID 23613400 3 citations (OpenAlex) Source: OpenAlex

  41. The immunohistochemical expression of c-Met is an independent predictor of survival in patients with glioblastoma multiforme

    Clinical & Translational Oncology, 2013

    DOI 10.1007/s12094-013-1059-4 PMID 23740136 25 citations (OpenAlex) Source: OpenAlex

  42. The SOCS-1 -1478CA/del Polymorphism is not Associated with Colorectal Cancer or Age at Onset in Turkish Subjects

    Asian Pacific Journal of Cancer Prevention, 2013

    DOI 10.7314/apjcp.2013.14.12.7583 PMID 24460337 5 citations (OpenAlex) Open-access full textSource: OpenAlex

  43. Rektum Kanserinde Sistemik Kemoterapi Uygulamaları

    Bursa Uludag University - AVESIS, 2013

    Source: OpenAlex

  44. Küçük Hücreli Akciğer Kanserli Bir Hastada Ektopik ACTH Sendromu: Olgu Sunumu

    DergiPark (Istanbul University), 2013

    Open-access full textSource: OpenAlex

  45. LOKAL İLERİ VEYA METASTAİK PANKREAS KANSERLİ HASTALARIMIZIN RETROSPEKTİF DEĞERLENDİRİLMESİ

    Bursa Uludag University - AVESIS, 2013

    Source: OpenAlex

  46. Prognostic significance of c-erbB2 overexpression in patients with metastatic gastric cancer

    Clinical & Translational Oncology, 2012

    DOI 10.1007/s12094-012-0921-0 PMID 22911549 17 citations (Europe PMC) Source: OpenAlex

  47. Pulmonary Actinomycosis Mimicking Metastasis from Lung Adenocarcinoma

    Onkologie, 2012

    DOI 10.1159/000342675 PMID 23038234 2 citations (Europe PMC) Source: OpenAlex

  48. Identification of prognostic factors in patients with metastatic gastrointestinal stromal tumors.

    PubMed, 2012

    PMID 23033292 Source: OpenAlex

  49. PharmaNews / PharmaTicker

    Onkologie, 2012

    DOI 10.1159/000312582 Open-access full textSource: OpenAlex

  50. Meetings and Conferences · Tagungen und Kongresse

    Onkologie, 2012

    DOI 10.1159/000178528 Open-access full textSource: OpenAlex